SCHEMBL299905

SCHEMBL299905

CCOC(=O)c1cc(OCCCO)c(OCCCO)cc1N

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.46
HSD17B10 Q99714 4/20 0.46
KDM4E B2RXH2 3/20 0.44
GAA P10253 2/20 0.42
MAPK1 P28482 1/20 0.42
DPP4 P27487 3/20 0.41
TSHR P16473 1/20 0.41
KMT2A Q03164 2/20 0.40
MEN1 O00255 1/20 0.40
CYP4F2 P78329 1/20 0.40
CYP4A11 Q02928 1/20 0.40
HPGD P15428 1/20 0.39
HSP90AA1 P07900 1/20 0.39
CA12 O43570 2/20 0.39
CA1 P00915 2/20 0.39
CA2 P00918 2/20 0.39
CA7 P43166 2/20 0.39
CA9 Q16790 2/20 0.39
CA14 Q9ULX7 2/20 0.39
NPC1 O15118 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1013314 0.86 HSD17B10 (0.53) ALDH1A1HSD17B10KDM4EGAAMAPK1
SCHEMBL264389 0.85 KDM4E (0.47) ALDH1A1HSD17B10KDM4EGAAMAPK1
Hydrochloric Acid SCHEMBL27984823 0.84 KDM4E (0.46) ALDH1A1HSD17B10KDM4EGAAMAPK1
SCHEMBL6401543 0.83 KDM4E (0.54) ALDH1A1HSD17B10KDM4EGAADPP4
SCHEMBL5500188 0.82 KDM4E (0.55) ALDH1A1HSD17B10KDM4EGAADPP4
SCHEMBL17854649 0.82 DPP4 (0.49) ALDH1A1HSD17B10KDM4EGAAMAPK1
SCHEMBL27889800 0.81 KDM4E (0.71) ALDH1A1HSD17B10KDM4EGAATSHR
SCHEMBL25037588 0.80 CYP1A2 (0.51) ALDH1A1HSD17B10KDM4EGAADPP4
SCHEMBL17836948 0.80 KDM4E (0.42) ALDH1A1HSD17B10KDM4EGAAMAPK1
SCHEMBL3373962 0.80 KDM4E (0.69) ALDH1A1HSD17B10KDM4EGAAMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8133999-B2 Process for preparation of 6, 7-bis(2-methoxyethoxy) quinazolin-4-one UBE INDUSTRIES, LTD. (JP) 2012-03-13 US disclosed
US-20090253909-A1 PROCESS FOR PREPARATION OF 6, 7-BIS (2-METHOXYETHOXY) QUINAZOLIN-4-ONE UBE INDUSTRIES, LTD. (JP) 2009-10-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090253909-A1 PROCESS FOR PREPARATION OF 6, 7-BIS (2-METHOXYETHOXY) QUINAZOLIN-4-ONE CYP4F11, OGFR, CYP4B1 ALDH1A1 897/4885HSD17B10 3223/4885KDM4E 93/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.